Home > Insider Trading > Filing (0001209191-18-051838)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510487	Principia Biopharma Inc.	PRNB	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	Sofinnova Ventures 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1245624	James Healy	Sofinnova Ventures 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1524064	Sofinnova Venture Partners Viii, L.p.	Sofinnova Ventures 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1559565	Sofinnova Management Viii, L.l.c.	Sofinnova Ventures 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1590102	Anand Mehra	Sofinnova Ventures 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-09-18	625,482	$0.00	625,482	No	4	C	Direct
Common Stock	Acquisiton	2018-09-18	521,235	$0.00	1,146,717	No	4	C	Direct
Common Stock	Acquisiton	2018-09-18	453,954	$0.00	1,600,671	No	4	C	Direct
Common Stock	Acquisiton	2018-09-18	167,537	$0.00	1,768,208	No	4	C	Direct
Common Stock	Acquisiton	2018-09-18	270,000	$17.00	2,038,208	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B-1 Preferred Stock	Disposition	2018-09-18	625,482	$0.00	625,482	$0.00
Common Stock	Series B-2 Preferred Stock	Disposition	2018-09-18	521,235	$0.00	521,235	$0.00
Common Stock	Series B-3 Preferred Stock	Disposition	2018-09-18	453,954	$0.00	453,954	$0.00
Common Stock	Series C Preferred Stock	Disposition	2018-09-18	167,537	$0.00	167,537	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant (Right to Buy)	$0.00		2022-12-29	20,938	20,938	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-12-29	20,938	20,938	Direct

Footnotes

Each share of the Series B-1 Preferred Stock converted immediately upon the closing of the Issuer's initial public offering of its common stock into 1 share of the Issuer's common stock.
The shares are held of record by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual managing members of SM VIII are Michael Powell, James Healy and Anand Mehra, and they may be deemed to share voting and dispositive power over the shares held by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares held by SVP VIII except to the extent of any pecuniary interest therein.
Each share of the Series B-2 Preferred Stock converted immediately upon the closing of the Issuer's initial public offering of its common stock into 1 share of the Issuer's common stock.
Each share of the Series B-3 Preferred Stock converted immediately upon the closing of the Issuer's initial public offering of its common stock into 1 share of the Issuer's common stock.
Each share of the Series C Preferred Stock converted immediately upon the closing of the Issuer's initial public offering of its common stock into 1 share of the Issuer's common stock.
This warrant has converted from a warrant to purchase Series B-3 Convertible Preferred Stock into a warrant to purchase Common Stock.
This warrant is exercisable at any time.